J. Aguirre-ghiso, Models, mechanisms and clinical evidence for cancer dormancy, Nature Reviews Cancer, vol.20, issue.11, p.834846, 2007.
DOI : 10.1038/nrc2256

D. A. August, P. H. Sugarbaker, and A. P. Schneider, Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer, Cancer, vol.6, issue.7, p.5514901494, 1985.
DOI : 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N

D. Barbolosi, A. Benabdallah, F. Hubert, and A. F. Verga, Mathematical and numerical analysis for a model of growing metastatic tumors, Mathematical Biosciences, vol.218, issue.1, p.114, 2009.
DOI : 10.1016/j.mbs.2008.11.008
URL : https://hal.archives-ouvertes.fr/hal-00262335

S. Benzekry, Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers, ESAIM: Mathematical Modelling and Numerical Analysis, vol.46, issue.2, p.207237, 2012.
DOI : 10.1051/m2an/2011041
URL : https://hal.archives-ouvertes.fr/hal-00518110

S. Benzekry, Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis, J Evol Equ, vol.11, issue.1, p.187213, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00516693

S. Benzekry, N. Andréandr´andré, A. Benabdallah, J. Ciccolini, C. Faivre et al., Modelling the impact of anticancer agents on metastatic spreading, Math Model Nat Phenom, vol.7, issue.1, p.306336, 2012.

S. Benzekry, A. Gandolfi-and-p, and . Hahnfeldt, Global Dormancy of Metastases Due to Systemic Inhibition of Angiogenesis, PLoS ONE, vol.63, issue.1, 2013.
DOI : 10.1371/journal.pone.0084249.t002
URL : https://hal.archives-ouvertes.fr/hal-00868592

A. Bethge, U. Schumacher, A. Wree-and-g, and . Wedemann, Are Metastases from Metastases Clinical Relevant? Computer Modelling of Cancer Spread in a Case of Hepatocellular Carcinoma, PLoS ONE, vol.126, issue.4, p.35689, 2012.
DOI : 10.1371/journal.pone.0035689.s007

W. C. Black and . Welch, Advances in Diagnostic Imaging and Overestimations of Disease Prevalence and the Benefits of Therapy, New England Journal of Medicine, vol.328, issue.17, p.12371243, 1993.
DOI : 10.1056/NEJM199304293281706

P. Chiarella, J. Bruzzo, R. P. Meiss, and A. R. Ruggiero, Concomitant tumor resistance, Cancer Letters, vol.324, issue.2, p.133141, 2012.
DOI : 10.1016/j.canlet.2012.05.021

A. Devys, T. Goudon-and-p, and . Lafitte, A model describing the growth and the size distribution of multiple metastatic tumors, Discrete and Continuous Dynamical Systems - Series B, vol.12, issue.4, p.731767, 2009.
DOI : 10.3934/dcdsb.2009.12.731
URL : https://hal.archives-ouvertes.fr/inria-00351489

W. D. Dewys, Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors, Cancer Res, vol.32, issue.2, p.374379, 1972.

A. A. Donofrio and . Gandolfi, Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by, Math Biosci, vol.191, issue.2, p.159184, 1999.

I. J. Fidler and . Paget, Timeline: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited, Nature Reviews Cancer, vol.3, issue.6, p.453458, 2003.
DOI : 10.1038/nrc1098

J. Folkman, Angiogenesis inhibitors generated by tumors, Mol Med, vol.1, issue.2, p.1202, 1995.

J. Folkman-and-r and . Kalluri, Cancer without disease, Nature, vol.427, issue.6977, p.787, 2004.
DOI : 10.1038/427787a

J. Folkman, Tumor angiogenesis: therapeutic implications, N Engl J Med, vol.285, p.11821186, 1971.

E. Gorelik, S. Segal, and M. Feldman, GROWTH OF A LOCAL TUMOR EXERTS A SPECIFIC INHIBITORY EFFECT ON PROGRESSION OF LUNG METASTASES, International Journal of Cancer, vol.24, issue.5, p.617625, 1978.
DOI : 10.1002/ijc.2910210512

E. Gorelik, Resistance of tumor-bearing mice to a second tumor challenge, Cancer Res, vol.43, issue.1, p.138145, 1983.

G. P. Gupta and . Massagu-e, Cancer Metastasis: Building a Framework, Cell, vol.127, issue.4, p.679695, 2006.
DOI : 10.1016/j.cell.2006.11.001
URL : http://doi.org/10.1016/j.cell.2006.11.001

P. Hahnfeldt, D. Panigraphy, J. Folkman-and-l, and . Hlatky, Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment, response and postvascular dormancy, Cancer Res, issue.19, p.5947704775, 1999.

D. A. Hanahan-and-r and . Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, p.646674, 2011.
DOI : 10.1016/j.cell.2011.02.013

L. Holmgren, M. S. Oreilly, and . Folkman, Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression, Nature Medicine, vol.218, issue.2, pp.149-153, 1995.
DOI : 10.1016/0022-3468(93)90246-H

K. Iwata, K. N. Kawasaki, and . Shigesada, A Dynamical Model for the Growth and Size Distribution of Multiple Metastatic Tumors, Journal of Theoretical Biology, vol.203, issue.2, p.177186, 2000.
DOI : 10.1006/jtbi.2000.1075

M. Nielsen, J. L. Thomsen, S. Primdahl, U. Dyreborg, and A. J. Andersen, Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies, British Journal of Cancer, vol.56, issue.6, p.56814819, 1987.
DOI : 10.1038/bjc.1987.296

M. S. Oreilly, L. Holmgren, Y. Shing, C. Chen, R. A. Rosenthal et al., Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma, Cell, vol.79, issue.2, p.7931528, 1994.
DOI : 10.1016/0092-8674(94)90200-3

M. S. Oreilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios et al., Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth, Cell, vol.88, issue.2, p.277285, 1997.
DOI : 10.1016/S0092-8674(00)81848-6

B. Perthame, Transport equations in biology, 2007.

R. T. Prehn, Two competing influences that may explain concomitant tumor resistance, Cancer Res, vol.53, issue.14, p.32669, 1993.

M. Retsky, R. Demicheli, W. Hrushesky, M. Baum, and I. Gukas, Surgery Triggers Outgrowth of Latent Distant Disease in Breast Cancer: An Inconvenient Truth?, Cancers, vol.2, issue.2, p.305337, 2010.
DOI : 10.3390/cancers2020305

E. Rofstad-and-b and . Graff, Thrombospondin-1-Mediated Metastasis Suppression by the Primary Tumor in Human Melanoma Xenografts, Journal of Investigative Dermatology, vol.117, issue.5, p.10429, 2001.
DOI : 10.1046/j.0022-202x.2001.01552.x

A. Sckell, N. Safabakhsh, M. Dellian, and R. K. Jain, Primary tumor sizedependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice, Cancer Res, issue.24, p.5858665869, 1998.

E. V. Sugarbaker, A. M. Cohen, and . Ketcham, Do metastases metastasize? Annals of surgery, p.1616, 1971.

C. R. Tait, D. Dodwell, . And, and . Horgan, Do metastases metastasize?, The Journal of Pathology, vol.203, issue.1, p.5158, 2004.
DOI : 10.1002/path.1544

O. V. Volpert, J. Lawler, and N. P. Bouck, A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1, Proceedings of the National Academy of Sciences, vol.95, issue.11, p.9563438, 1998.
DOI : 10.1073/pnas.95.11.6343

H. G. Welch and . Black, Overdiagnosis in Cancer, JNCI Journal of the National Cancer Institute, vol.102, issue.9, p.60513, 2010.
DOI : 10.1093/jnci/djq099